Jakarta, Santas-id.com - Ema Medical Agency (EMA) is concerned about the emergence of the new Covid-19 new variant this winter. Booster injection Campaign has been issued.
Booster vaccine campaigns to address new wave concerns of the Covid-19 case at the end of the year continue to play. It was delivered by a group of European Union with 27 countries.
"There may be an entirely new variant emerging which we can't predict today," said the head of the EMA vaccine Marco Cavalry, as quoted, Saturday (3 / 9 / 2022).
He said, the new Covid-19 variant this winter may have come from the previous Omicron variant which has now been largely dominated by type BA.4 and 5.
They also believe that, that, that, that vaccine that exists today, could still prevent patients from being exposed to the Corona virus from serious disease and death.
Soon there will be a vaccine that's already adapted to the dominant type of Omicron. The scope is a newly approved mixture of injections.
While the original vaccine will continue to be developed to continue to counteract the spread of the virus discovered first in China 2019.
The EMA has also agreed to an adaptable vaccine to address the existing Omicron subvariant BA.1.
Among them, Pfizer / BioNTech and Moderna, the updated version of Vaccin Pfizer for BA.4 and 5 variants which are now dominant must be passed in the middle of September. As for the modern vaccine that was also adapted is also in process.
Even so, the Cavalry reveals, a new type of injection of vaccine adjusted to this Omicron will mostly be provided for a booster for parents, who are vulnerable, pregnant women and health workers.
